Innate immunity in systemic lupus erythematosus: Sensing endogenous nucleic acids

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 206-211

  Kontaki, Elena ^a,b   Boumpas, Dimitrios T ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

Dendritic cells; Genes; IFN ; NLRs; RLRs; TLRs

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; DNA; INTERFERON ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 18; NUCLEIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CLINICAL TRIAL; DENDRITIC CELL; HUMAN; IMMUNOGENICITY; INNATE IMMUNITY; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; APOPTOSIS; AUTOANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; NUCLEIC ACIDS; RECEPTORS, PATTERN RECOGNITION; STRESS, PHYSIOLOGICAL;

EID: 77957765210     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.009     Document Type: Article

References (55)

1. Gregersen P.K. Modern genetics, ancient defenses, and potential therapies. N Engl J Med 2007, 356:1263-1266.
2. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
3. Hooks J.J., Moutsopoulos H.M., Geis S.A., Stahl N.I., Decker J.L., Notkins A.L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979, 301:5-8.
4. Bave U., Vallin H., Alm G.V., Ronnblom L. Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines. J Autoimmun 2001, 17:71-80.
5. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
6. Moser K.L., Kelly J.A., Lessard C.J., Harley J.B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009, 10:373-379.
7. Kariuki S.N., Kirou K.A., MacDermott E.J., Barillas-Arias L., Crow M.K., Niewold T.B. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 2009, 182:34-38.
8. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003, 100:2610-2615.
9. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005, 52:1491-1503.
10. Santer D.M., Yoshio T., Minota S., Moller T., Elkon K.B. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol 2009, 182:1192-1201.
11. Crow M.K. Developments in the clinical understanding of lupus. Arthritis Res Ther 2009, 11:245.
12. Elkon K.B. Autoimmunity: apoptotic fats grease transcription. Nat Med 2009, 15:1246-1248.
13. Denny M.F., Chandaroy P., Killen P.D., Caricchio R., Lewis E.E., Richardson B.C., et al. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol 2006, 176:2095-2104.
14. Theofilopoulos A.N., Gonzalez-Quintial R., Lawson B.R., Koh Y.T., Stern M.E., Kono D.H., et al. Sensors of the innate immune system: their link to rheumatic diseases. Nat Rev Rheumatol 2010, 6:146-156.
15. Baccala R., Gonzalez-Quintial R., Lawson B.R., Stern M.E., Kono D.H., Beutler B., et al. Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 2009, 5:448-456.
16. Papadimitraki E.D., Bertsias G.K., Boumpas D.T. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 2007, 29:310-318.
17. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 2002, 416:603-607.
18. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005, 202:1171-1177.
19. Kono D.H., Haraldsson M.K., Lawson B.R., Pollard K.M., Koh Y.T., Du X., et al. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci U S A 2009, 106:12061-12066.
20. Boule M.W., Broughton C., Mackay F., Akira S., Marshak-Rothstein A., Rifkin I.R. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004, 199:1631-1640.
21. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8:487-496.
22. Urbonaviciute V., Furnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008, 205:3007-3018.
23. Papadimitraki E.D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., et al. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 2006, 54:3601-3611.
24. Nakou M., Papadimitraki E.D., Choulaki C., Goulidaki N., Moutafi M., Koutala E., et al. Synergistic action of interleukin 21 (IL-21) and TLR-9 to promote B-cell differentiation in active SLE. Ann Rheum Dis 2008, 67(Suppl. II):102.
25. Papadimitraki E.D., Tzardi M., Bertsias G., Sotsiou E., Boumpas D.T. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response. Lupus 2009, 18:831-835.
26. Kuhn A., Krammer P.H., Kolb-Bachofen V. Pathophysiology of cutaneous lupus erythematosus-novel aspects. Rheumatology (Oxford) 2006, 45(Suppl. 3):iii14-iii16.
27. Feldmeyer L., Keller M., Niklaus G., Hohl D., Werner S., Beer H.D. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 2007, 17:1140-1145.
28. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356:1216-1225.
29. Burckstummer T., Baumann C., Bluml S., Dixit E., Durnberger G., Jahn H., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009, 10:266-272.
30. Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
31. Krieg A.M. AIMing 2 detect foreign DNA. Sci Signal 2009, 2:pe39.
32. Ting J.P., Duncan J.A., Lei Y. How the noninflammasome NLRs function in the innate immune system. Science 2010, 327:286-290.
33. Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009, 460:269-273.
34. Yasutomo K., Horiuchi T., Kagami S., Tsukamoto H., Hashimura C., Urushihara M., et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001, 28:313-314.
35. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
36. Rice G.I., Bond J., Asipu A., Brunette R.L., Manfield I.W., Carr I.M., et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009, 41:829-832.
37. Denny M.F., Thacker S., Mehta H., Somers E.C., Dodick T., Barrat F.J., et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007, 110:2907-2915.
38. Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008, 8:594-606.
39. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
40. Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009, 206:1983-1994.
41. Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009, 15:623-625.
42. Fairhurst A.M., Xie C., Fu Y., Wang A., Boudreaux C., Zhou X.J., et al. Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J Immunol 2009, 183:6831-6838.
43. Triantafyllopoulou A., Franzke C.W., Seshan S.V., Perino G., Kalliolias G.D., Ramanujam M., et al. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A 2010, 107:3012-3017.
44. Quan T.E., Roman R.M., Rudenga B.J., Holers V.M., Craft J. Epstein-barr virus promotes interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum 2010.
45. Visentini M., Conti V., Cagliuso M., Tinti F., Siciliano G., Trombetta A.C., et al. Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency. Arthritis Rheum 2009, 60:2767-2771.
46. Barrat F.J., Coffman R.L. Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol Rev 2008, 223:271-283.
47. Kim W.U., Sreih A., Bucala R. Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun Rev 2009, 8:204-208.
48. Moutsopoulos H.M., Gallagher J.D., Decker J.L., Steinberg A.D. Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum 1978, 21:798-802.
49. Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009, 27:621-668.
50. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
51. Mackay I.R. Clustering and commonalities among autoimmune diseases. J Autoimmun 2009, 33:170-177.
52. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
53. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.
54. Ikehara S. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases. J Autoimmun 2008, 30:108-115.
55. Gershwin M.E. The mosaic of autoimmunity. Autoimmun Rev 2008, 7:161-163.